Status:
COMPLETED
A Retrospective Study of Severe Plasmodium Vivax
Lead Sponsor:
University of Oxford
Conditions:
Malaria, Vivax
Eligibility:
All Genders
Brief Summary
Historically, Plasmodium vivax has been termed "benign" due to its non-life threatening clinical course and since the 1800's this view has been cultivated as demonstrated by the use of the term "benig...
Eligibility Criteria
Inclusion
- Patients voluntarily presented at SMRU clinic during 2001-2016 with a diagnosis of P. vivax mono-infection
Exclusion
- Patients voluntarily presented at SMRU clinic during 2001-2016 with fever and were seeking consultation for the treatment of malaria or other infections.
Key Trial Info
Start Date :
October 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2020
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT03307369
Start Date
October 27 2017
End Date
July 15 2020
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shoklo Malaria Research Unit
Mae Sot, Changwat Tak, Thailand, 63110